Cti Biopharma

Developer of targeted small molecule therapeutics for blood cancer

placeSeattle, Washington, United States calendar_todayFounded 1991 groups25 employees language ctibiopharma.com

Registered entities

Investor mix

6 investors on record; 1 has since exited.

Investor typeCountShare
Venture capital467%
Private equity117%
Bank & private debt117%
Coming soon